Rikoon Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,174
Closed -$216K 208
2019
Q3
$216K Sell
2,174
-100
-4% -$9.5K 0.08% 193
2019
Q2
$210K Hold
2,274
0.08% 196
2019
Q1
$215K Buy
+2,274
New +$199K 0.08% 193
2018
Q3
Sell
-2,984
Closed -$237K 217
2018
Q2
$237K Sell
2,984
-1,147
-28% -$95.2K 0.09% 188
2018
Q1
$359K Sell
4,131
-365
-8% -$35K 0.15% 141
2017
Q4
$469K Sell
4,496
-2,581
-36% -$291K 0.19% 111
2017
Q3
$1.03M Buy
7,077
+350
+5% +$47.7K 0.45% 64
2017
Q2
$873K Buy
6,727
+190
+3% +$23.3K 0.39% 71
2017
Q1
$811K Buy
+6,537
New +$782K 0.36% 81

Other funds holding CELG

Rikoon Group's CELG Position: Q4 2019 in Review

Rikoon Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,174 shares — an estimated $216K sold.

Rikoon Group first reported a position in CELG in Q1 2017 and held it in 9 quarters. The position peaked at $1.03M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Rikoon Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Rikoon Group sold 2,174 Celgene Corp shares in Q4 2019, an estimated $216K.
  • Rikoon Group first reported a position in Celgene Corp in Q1 2017 and held it in 9 quarters.
  • Rikoon Group's Celgene Corp position peaked at $1.03M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Rikoon Group's 13F filing for Q4 2019, filed 21 Jan 2020.